Search Results for: RAB2A

30 interactions involving RAB2A - RAB2A, member RAS oncogene family found:

Sort by: Symbol Number of Pathways Number of Drugs Number of Diseases
Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
MAPKAPK3 MAPK activated protein kinase 3
  • p38MAPK events
  • Oxidative Stress Induced Senescence
  • VEGFA-VEGFR2 Pathway
  • activated TAK1 mediates p38 MAPK activation
  • 2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE
  • 2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE
PMAIP1 phorbol-12-myristate-13-acetate-induced protein 1
  • Activation of NOXA and translocation to mitochondria
  • BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members
  • TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
PRKCI protein kinase C iota
  • Pre-NOTCH Transcription and Translation
  • p75NTR recruits signalling complexes
  • Tight junction interactions
  • Tamoxifen
  • Bisindolylmaleimide I
  • Fostamatinib
RBSN rabenosyn, RAB effector
  • Toll Like Receptor 9 (TLR9) Cascade
  • Factors involved in megakaryocyte development and platelet production
RGS2 regulator of G protein signaling 2
  • G alpha (q) signalling events
SGSM2 small G protein signaling modulator 2
STAMBPL1 STAM binding protein like 1
  • Metalloprotease DUBs
TBC1D25 TBC1 domain family member 25
  • TBC/RABGAPs
TMEM70 transmembrane protein 70
  • Mitochondrial respiratory chain deficiencies (MRCD), including: Mitochondrial complex I deficiency (MT-C1D); Complex II deficiency (MT-C2D); Complex III deficiency (MT-C3D); Complex IV deficiency (MT-C4D); Complex V deficiency (MT-ATPSD); Leigh syndrome (LS); Kearns-Sayre Syndrome (KSS); LCHD deficiency (LCHD); Leber Hereditary Optic Neuropathy (LHON); Myoclonic Epilepsy and Ragged-Red Fiber Disease (MERRF); NARP; MELAS; ACAD9 deficiency; HADH deficiency; HIBCH deficiency; GRACILE syndrome
TRIM7 tripartite motif containing 7

Page 2 out of 2 pages